Suchergebnisse
Immatics is a biotech company that discovers and develops targets for T cell-based immunotherapies against solid tumors. Learn more about their mission, pipeline, and partnerships with global pharmaceutical leaders.
- Inside Immatics
Immatics Biotechnologies GmbH Paul-Ehrlich-Str. 15 72076...
- Pipeline
From its research and development origins in Tübingen,...
- UNLOCKING CANCER IMMUNOTHERAPIES
Immatics’ investigational immunotherapies are designed to...
- Investors & Media
Immatics US, Inc. 2201 W. Holcombe Blvd., Suite 205 Houston,...
- About
Immatics has identified and characterized a trove of novel...
- Leadership
Leadership - Immatics
- Board of Directors
Board of Directors - Immatics
- Scientific Advisory Board
Scientific Advisory Board - Immatics
- Inside Immatics
Immatics is a biotech company developing targeted TCR-based immunotherapies for solid tumors. It offers two distinct therapeutic modalities: Adoptive Cell Therapies (ACT) and TCR Bispecifics (TCER®), as well as collaborations with BMS and Genmab.
IMMATICS AKTIE und aktueller Aktienkurs. Nachrichten zur Aktie Immatics N.V. Registered Shs | A2P72S | IMTX | NL0015285941
- IMTX
- A2P72S
- NL0015285941
Immatics develops T cell redirecting immunotherapies for the treatment of cancer. Learn about its clinical trials, products, and patient stories on its website.
Basierend auf den pr äklinischen Proof -of-Concept Daten, die vollständige Remissionen von transplantierten menschlichen Tumoren in Xenograft-Mausmodellen zeigen, wird IMA401 nun in der Phase-1-Studie in Patienten mit MAGEA4/8-positiven Tumoren untersucht.
11. Sept. 2023 · Moderna and Immatics announce a strategic partnership to develop novel mRNA-based cancer vaccines and TCR molecules. The collaboration will leverage Immatics’ XPRESIDENT® and XCUBE™ platforms and Moderna’s mRNA technology.
9. Nov. 2021 · ACTengine® IMA203 wird derzeit in einer laufenden Phase-1a-Dosis-Eskalationsstudie unter Verwendung eines 3+3-Designs mit vier aufsteigenden Dosisstufen untersucht, um die empfohlene Phase-2-Dosis ( Recommended Phase 2 Dose, RP2D) zu ermitteln.
